Soluble vascular endothelial (VE) cadherin and autoantibodies to VE-cadherin in rheumatoid arthritis patients treated with etanercept or adalimumab

Banse, C; Polena, H; Stidder, B; Khalil-Mgharbel, A; Houivet, E; Lequerre, T; Fardellone, P; Le-Loet, X; Philippe, P; Marcelli, C; Vittecoq, O; Vilgrain, I

Banse, C (reprint author), Serv Rhumatol, 1 Rue Germont, F-76000 Rouen, France.

JOINT BONE SPINE, 2017; 84 (6): 685

Abstract

Objectives: The aim of this study was to investigate the clinical value of sVE and anti-vascular endothelial-cadherin antibodies (AAVE) in RA treated ......

Full Text Link